Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chan

Showing results (561-570 of 587) with videos related to

Pageof 59
Sort By:
Nature Immunology|August 7, 2007
Development, cytokine profile and function of human interleukin 17-producing helper T cellsNicholas J Wilson, Katia Boniface, Jason R Chan, et al.
Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
American Heart Journal|May 29, 2000
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trialE J Topol, J D Easton, P Amarenco, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Journal of Medical Internet Research|May 16, 2021
Clinical Outcomes of Asynchronous Versus Synchronous Telepsychiatry in Primary Care: Randomized Controlled TrialPeter M Yellowlees, Michelle Burke Parish, Alvaro D Gonzalez, et al.
Nature Medicine|February 12, 2008
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumoniaShean J Aujla, Yvonne R Chan, Mingquan Zheng, et al.
Elife|September 28, 2016
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryFeng Mei, Klaus Lehmann-Horn, Yun-An A Shen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2022
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosisAhmed Abdelhak, Christian Cordano, W John Boscardin, et al.
Pageof 59

Showing results (561-570 of 587) with videos related to

Sort By:
Pageof 59
Nature Immunology|August 7, 2007
Development, cytokine profile and function of human interleukin 17-producing helper T cellsNicholas J Wilson, Katia Boniface, Jason R Chan, et al.
Stroke|June 10, 2006
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurementsB D Murphy, A J Fox, D H Lee, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
American Heart Journal|May 29, 2000
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trialE J Topol, J D Easton, P Amarenco, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Brain : a Journal of Neurology|December 16, 2017
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injuryBruce A C Cree, Jianqin Niu, Kimberly K Hoi, et al.
Journal of Medical Internet Research|May 16, 2021
Clinical Outcomes of Asynchronous Versus Synchronous Telepsychiatry in Primary Care: Randomized Controlled TrialPeter M Yellowlees, Michelle Burke Parish, Alvaro D Gonzalez, et al.
Nature Medicine|February 12, 2008
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumoniaShean J Aujla, Yvonne R Chan, Mingquan Zheng, et al.
Elife|September 28, 2016
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryFeng Mei, Klaus Lehmann-Horn, Yun-An A Shen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2022
Plasma neurofilament light chain levels suggest neuroaxonal stability following therapeutic remyelination in people with multiple sclerosisAhmed Abdelhak, Christian Cordano, W John Boscardin, et al.
Pageof 59